ECRI Newsroom

ECRI Newsroom

Read the latest news about ECRI’s independent research and initiatives to advance effective, evidence-based healthcare globally.

News Releases

Guidance for navigating supply chain disruptions caused by faulty syringes from China

Affected syringes are leaking, cracking, and breaking – putting patients at risk of receiving incorrect doses of medication, risking serious injury or death.

Latest News

News Release

News Release

Global patient safety nonprofit releases guidance for navigating supply chain disruptions caused by faulty syringes from China

The FDA has been warning healthcare providers and the public about malfunctioning plastic syringes made in China since November 2023. The affected syringes are leaking, cracking, and breaking –...

News Release

News Release

ECRI names new Chief Technology Officer Darryl Goss to spearhead technology advancements

ECRI, an independent, nonprofit patient safety organization that provides technology solutions and evidence-based guidance to healthcare decision-makers, has named Darryl Goss its new Chief Techno...

News Release

News Release

Increase in ransomware attacks to healthcare's vulnerable remote access systems threatens patients

Nonprofit patient safety organization releases hazard report, recommendations Ransomware groups are increasingly targeting vulnerable remote access systems in healthcare, with several high-profile...

View all

Stay In the Know

Join our community to receive valuable resources, tools, and insights directly in your inbox.

Blog Posts

Infection Prevention

What Hospitals Need to Know: Using Water During Processing of Medical Devices

Every day, hospitals’ central sterile processing teams rely on water as they clean and sterilize a variety of medical devices. In this blog, ECRI outlines general considerations to support safe and...

Evidence-based Decision Making

Using Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs

Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight loss—Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—could potentially make much needed g...

Patient Safety

ECRI’s Top 10 Patient Safety Concerns for 2024

ECRI recently published our Top 10 Patient Safety Concerns for 2024 Special Report—the annual guide that calls attention to pressing patient safety concerns facing the healthcare industry. For thi...

View all

Social Media

ECRI

Media Inquiries

For media inquiries and interviews with ECRI’s subject matter experts, please contact Yvonne Rhodes, Associate Director of Strategic Communications, at yrhodes@ecri.org.